Richard Kobza

Showing 1-3 of 3 articles

Interventions for valvular disease

First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation

Toggweiler S, De Boeck B, Brinkert M, Buhmann R, Bossard M, Kobza R, Cuculi F

September 20, 2018 | 10.4244/EIJ-D-18-00440

Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation

Toggweiler S, Nissen H, Mogensen B, Cuculi F, Fallesen C, Veien K, Brinkert M, Kobza R, Rück A

December 20, 2017 | 10.4244/EIJ-D-17-00252

Coronary interventions

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold

Jamshidi P, Nyffenegger T, Sabti Z, Buset E, Toggweiler S, Kobza R, Cuculi F

April 20, 2016 | 10.4244/EIJV11I13A287

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease